The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
Karolinska Institutet (KI) is one of the world’s leading medical universities. Its vision is to significantly contribute to the improvement of human health. KI accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at KI selects the Nobel laureates in Physiology or Medicine.
As part of Karolinska Institutet, Ming Wai Lau Centre for Reparative Medicine (MWLC) is established to significantly contribute to the improvement of human health by conducting cutting edge research in reparative medicine and related subjects, by creating a new platform for synergies between academia and innovation in Sweden and Hong Kong as well as China, and fostering future leaders in both academia and industry.
The Hong Kong node of MWLC will focus on establishing a technology hub exploring novel technologies, including genome editing, reprogramming, single cell transcriptomics, biomedical engineering, and 3D tissue imaging technologies, with specialty areas of stem cell-based regeneration of the heart, skin, liver and nervous systems. The Centre will develop and engage in research courses, workshops, and symposiums at both the Stockholm and Hong Kong nodes, to enhance interactions of the research communities in Karolinska Institutet, Hong Kong, Mainland China and the rest of the world, and to nurture opportunities for inter-institutional collaboration.